Jiangsu Bioperfectus Technologies Co Ltd (688399) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.007x

Based on the latest financial reports, Jiangsu Bioperfectus Technologies Co Ltd (688399) has a cash flow conversion efficiency ratio of 0.007x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥20.00 Million ≈ $2.93 Million USD) by net assets (CN¥2.97 Billion ≈ $434.25 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Jiangsu Bioperfectus Technologies Co Ltd (688399) net asset quality to measure how much of total assets are equity-financed.

Jiangsu Bioperfectus Technologies Co Ltd - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Jiangsu Bioperfectus Technologies Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is Jiangsu Bioperfectus Technologies Co Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.

Jiangsu Bioperfectus Technologies Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jiangsu Bioperfectus Technologies Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Qibu Co Ltd SHG:603557	-0.263x
Advancetek Enterprise Co Ltd TW:1442	-0.034x
Jash Engineering Limited NSE:JASH	0.055x
DiaMedica Therapeutics Inc NASDAQ:DMAC	-0.192x
Agencia Comercial Spirits Ltd Class A Ordinary Shares NASDAQ:AGCC	N/A
Cion Investment Corp NYSE:CION	-0.004x
Sysgration Ltd TWO:5309	-0.013x
Guangzhou Shangpin Home Collection Co Ltd SHE:300616	0.018x

Annual Cash Flow Conversion Efficiency for Jiangsu Bioperfectus Technologies Co Ltd (2016–2024)

The table below shows the annual cash flow conversion efficiency of Jiangsu Bioperfectus Technologies Co Ltd from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see Jiangsu Bioperfectus Technologies Co Ltd (688399) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥3.25 Billion ≈ $475.67 Million	CN¥145.93 Million ≈ $21.35 Million	0.045x	+235.10%
2023-12-31	CN¥3.41 Billion ≈ $498.27 Million	CN¥-113.14 Million ≈ $-16.56 Million	-0.033x	-106.39%
2022-12-31	CN¥3.78 Billion ≈ $552.86 Million	CN¥1.96 Billion ≈ $287.52 Million	0.520x	+33.85%
2021-12-31	CN¥2.54 Billion ≈ $371.16 Million	CN¥985.52 Million ≈ $144.21 Million	0.389x	-30.90%
2020-12-31	CN¥1.66 Billion ≈ $243.57 Million	CN¥935.88 Million ≈ $136.95 Million	0.562x	+437.82%
2019-12-31	CN¥1.02 Billion ≈ $149.37 Million	CN¥106.72 Million ≈ $15.62 Million	0.105x	-60.52%
2018-12-31	CN¥324.10 Million ≈ $47.43 Million	CN¥85.82 Million ≈ $12.56 Million	0.265x	+11.90%
2017-12-31	CN¥260.28 Million ≈ $38.09 Million	CN¥61.59 Million ≈ $9.01 Million	0.237x	+169.80%
2016-12-31	CN¥251.90 Million ≈ $36.86 Million	CN¥22.09 Million ≈ $3.23 Million	0.088x	--

About Jiangsu Bioperfectus Technologies Co Ltd

SHG:688399 China Biotechnology

Market Cap

$340.21 Million

CN¥2.32 Billion CNY

Market Cap Rank

#14210 Global

#4237 in China

Share Price

CN¥27.72

Change (1 day)

+0.80%

52-Week Range

CN¥23.79 - CN¥84.90

All Time High

CN¥419.88